Nyheter

10 november, 2022, Övrig nyhet

Triglycerider – de okända blodfetterna

De flesta känner till att ett högt kolesterolvärde inte är bra. Att det ökar risken för hjärt- och kärlsjukdomar. Inte lika många känner till att den andra typen av ”farliga” blodfetter – triglyceriderna – också behöver hållas i schack. På Lipigon ho...

25 augusti, 2020, Övrig nyhet

Lipigon-CombiGene collaboration reaches milestone

The collaboration between Lipigon and CombiGene has reached a milestone. CombiGene announced today that a patent application has been filed. Read more in their press release (in Swedish). Combigene Press release

10 oktober, 2019, Övrig nyhet

LIPIGON ENTERS LICENSING AND COLLABORATION AGREEMENT WITH COMBIGENE TO DEVELOP GENE THERAPY FOR LIPO

“We are very happy to enter this agreement with CombiGene ,” says Stefan K Nilsson, CEO at Lipigon. “Through the development of their epilepsy project, CombiGene has demonstrated a fantastic ability to handle the complexities of gene therapy. With ou...

24 september, 2017, Övrig nyhet

LIPIGON HAS BEEN NOMINATED AS UNIVERSITY SPIN-OUT OF THE YEAR

Lipigon is nominated as this year’s spin-out company at UmeåGalan2017. As 1 of 3 nominees Lipigon has the chance to win the prestigious price November 9th. “The nomination as such is very honoring. It is another hallmark and confirmation of that we a...

2 juni, 2016, Övrig nyhet

LIPIGON CEO STEFAN K. NILSSON IN INTERVIEW AS INVITED SPEAKER FOR BIOFIT 2016

Lipigon CEO Stefan K. Nilsson is an invited speaker at BioFIT 2016 in Lille, France November 30th-December 1st. Dr. Nilsson will speak at the session “Are universities a short-term or long-term partner for spin offs?”. Bio-FIT is a leading partnering...

2 mars, 2016, Övrig nyhet

MIKAEL ELOFSSON INTERVIEWED AT ADD 2016

Lipigon board member Prof. Mikael Elofsson presented a screening-based approach to identify small molecules that stabilize and activate lipoprotein lipase, the key enzyme in lipid metabolism, at the Academic Drug Discovery meeting in Cambridge, UK. ...

1 mars, 2016, Övrig nyhet

AVAILABLE POSITIONS

Lipigon is expanding and looking for new talents to join our team. We are looking for; Project manager/laboratory manager with work experience from pharmaceutical industry and QC/validation. Laboratory assistants with experience from in vitro and...

3 februari, 2016, Övrig nyhet

LIPIGON AWARDED CONNECT´S PITCH PRIZE

Lipigon awarded Connect´s pitch prize at Biotech Umeå investment Day at Grand Hôtel Stockholm.

9 december, 2015, Övrig nyhet

LIPIGON PATENT APPLICATION PUBLISHED

Lipigon’s first patent application “New plasma lipid lowering agents” were published today as #WO 2015/187082.

1 september, 2015, Övrig nyhet

LIPIGON SCIENTISTS PUBLISH IN PRESTIGIOUS JOURNAL

Lipigon scientists publish SAR relationship in Eur J Med Chem. For further reading; Structure-activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo, Caraballo et al.

1 maj, 2015, Övrig nyhet

LIPIGON CEO TO FRONT NATIONAL SSMF CAMPAIGN

CEO Stefan K Nilsson is one of out of five promising young scientists that has been selected to front the Swedish Society for Medical Research’s fund raising campaign. The advertisements can been seen in national newspapers and magazine during the sp...

4 september, 2014, Övrig nyhet

LIPIGON CEO STEFAN K NILSSON RECEIVES SSMF POSTDOCTORAL AWARD

Lipigon CEO Dr. Stefan K Nilsson has been awarded the Swedish Society for Medical Research postdoctoral support. Read more about the award here, in Swedish.

27 juni, 2014, Övrig nyhet

LIPIGON SCIENTISTS IDENTIFIES LPL ACTIVATORS

Lipigon scientists publish results for first LPL activators in Biochem Biophys Res Commun. For further reading; Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo, Larsson et al.

26 januari, 2014, Övrig nyhet

LIPIGON ATTENDS: BIOTECH UMEÅ INVESTMENT DAY

Lipigon attends: Biotech Umeå investment Day at Grand Hotel Stockholm to tuesday 27/1-2015.

17 januari, 2014, Övrig nyhet

LIPIGON ATTENDS: SWISS-SWEDEN

Lipigon attends: Swiss-Sweden

Nyheter

28 november, 2022, Pressmeddelande

Lipigons vd Stefan K. Nilsson ökar sitt innehav i bolaget

Lipigon Pharmaceuticals AB ("Lipigon") meddelar i dag att vd Stefan K. Nilsson har köpt aktier i Lip...

24 november, 2022, Pressmeddelande

Lipigon publicerar delårsrapport för januari-september 2022

Lipigon Pharmaceuticals AB ("Lipigon") publicerar i dag sin delårsrapport för perioden 1 januari-30 ...

14 november, 2022, Pressmeddelande

Umeå på börsen

Lipigon Pharmaceuticals AB ("Lipigon") anordnar tillsammans med andra börsnoterade bolag från Umeå e...